Please click on links below for further information

** If there is no link available, details can be found on the MHRA (Medicines & Healthcare products Regulatory Agency) website

Latest Field safety notice, national patient safety alert, device safety information, and medicines recall/notification-August 2025

Field safety notice, national patient safety alert, device safety information, and medicines recall/notification-August 2025

Speak to your dispensing pharmacy for more information if you think this relates to medication you take

August 2025

July 2025

• CAS-ViewAlert: National Patient Safety Alert – Potential contamination of non-sterile alcohol-free skin cleansing wipeswith Burkholderia spp: measures to reduce patient risk
• Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution, Laboratoires Théa EL(25)A/34 – increased risk of microbial contamination of the medicinal product.

Archive

• Class 2 Medicines Recall: Tesco Health Dry Cough Release 200ml, Asda Strong Dry Tickly Cough 200ml, Almus Dry Cough Relief and Bells Dual Action Dry Cough, EL(25) A/03 Updated
• Class 2 Medicines Recall: Pfizer Limited, Oxbryta 500mg Tablets (voxelotor), EL(24)A/44
• Class 3 Medicines Recall: Accord-UK Ltd, Trandolapril 0.5mg, 2mg, 4mg Capsules, EL(24)A/35
• Class 4 Medicines Defect Information: Sandoz Limited, Omeprazole products, EL(24)A/34
• Class 4 Medicines Defect Information: Dawa Limited, Paracetamol 500mg, 1000mg Film-Coated Tablets, EL (24)A/21
• Class 4 Medicines Defect Information: Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets, EL (24)A/07
• Class 3 Medicines Recall: Torrent Pharma (UK) Limited, Ramipril 1.25mg tablets, EL(24)A/05

• Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023
• Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023
  • Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c 10th April 2023
  • Serious Shortage Protocols (SSP) for clarithromycin 125mg/5ml and 250mg/5ml oral suspension were issued on 06/04/2023
• Wockhardt is out of stock oxycodone 5mg/5ml oral solution until end of June 2023.
• Class 4 Medicines Defect Information: Albireo AB, Bylvay 1200 micrograms Hard Capsules, EL (23)A/01 – GOV.UK (www.gov.uk)
• Prenoxad 1mg/ml Solution for Injection in a pre-filled syringe, Macarthys Laboratories, (Aurum Pharmaceuticals Ltd), caution due to potential needles in sealed kits https://www.cas.mhra.gov.uk/ViewAndAcknowledgment/viewAlert.aspx?AlertID=103215
• MHRA – Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38    Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38 – GOV.UK (www.gov.uk)
•  Recall of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion   https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-amiodarone-hydrochloride-50-mg-slash-ml-concentrate-for-solution-for-injection-slash-infusion-el-22-a-slash-31
•  Abbott recalls two infant formula powders because of the possible presence of Salmonella  Feb 2022    Please see link to FSA recall: https://www.food.gov.uk/news-alerts/alert/fsa-prin-11-2022          
• Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets       Oct 21
• Emerade   Emerade 300mcg Patient Letter   Emerade 500mcg Patient Letter
• Phyllocontin (Aminophylline) 225mg And 350mg Modified Release Tablets (Update On Sda/2021/003 Issued On 9 February 2021 Regarding Stock Exhaustion Date For  Phyllocontin (Aminophylline) Continus 225mg).  SDA-2021-003(U).pdf
• Choral Hydrate 143.3/Ranitidine    April 21
• Fluoxetine 10mg                                April 21
• Diamorphone limited supply           April 21
• Inhaled Budesonaide                       April 21
• Pneomovax 23 solution                  April 21
•  Estradot® 75 microgram patches  May 21      a Serious Shortage Protocol (SSP) has been issued for Estradot^® 75 microgram patches.  The SSP will enable community pharmacists in England and Wales to supply patients with Evorel^® 75 microgram patches OR Estraderm MX^® 75 microgram patches.
• Urgent Assessment/Treatment Following Ingestion Of ‘Super Strong’ Magnets
• MSN_2020_055U Desmopressin (DDAVP) 0.01% w_v (100mcg per 1ml) intranasal solution                                                   June 21
• Recall Of Co-Codamol 30/500 Effervescent Tablets, Batch 1k10121, Zentiva Pharma Uk Ltd NatPSA_2021_004_MHRA – co-codamol          June 21
• Dexamethasone 0.1% (Maxidex®) 5ml eye drops      June 21
•  Champix ® (varenicline) 0.5mg and 1mg tablets – Supply Disruption           June 21